Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu Better Than GHK Copper: Formulation Comparison

The table below compares properly chelated GHK-Cu against common 'GHK copper' formulations sold without chelation verification. These distinctions determine whether research outcomes align with published protocols. Research-Grade GHK-Cu (chelated) SPPS with in

This source-based comparison does not add ratings or recommend a winner.

  • The table below compares properly chelated GHK-Cu against common 'GHK copper' formulations sold without chelation verification. These distinctions determine whether research outcomes align with published protocols.
  • Research-Grade GHK-Cu (chelated)
  • SPPS with in-process copper chelation at pH 7.0–7.4
  • Stable 21–28 days at 2–8°C
  • High—matches published trial material
  • CoA with UV-Vis at 620 nm or MS confirmation of complex
  • Gold standard for replicable research—only formulation proven in peer-reviewed trials
  • GHK + Copper Salts (non-chelated)
  • Peptide synthesised separately, copper chloride or sulfate added at reconstitution
  • Degrades within 24–48 hours; pH-sensitive
  • Low to negligible—free copper generates oxidative damage
  • No standard verification method; user assumes chelation occurs
  • Unsuitable for research requiring consistency—chelation yield varies with every batch
  • Pre-Mixed 'GHK Copper' (undefined ratio)
  • Industrial-scale synthesis with copper added during lyophilization
  • Variable—partial chelation may occur
  • Moderate if ratio is correct; unpredictable otherwise
  • Batch-specific CoA required but rarely provided
  • Risk profile too high for controlled studies—no way to confirm what percentage exists as active complex
  • GHK Alone (no copper)
  • Standard SPPS without metal chelation
  • Stable as lyophilised powder indefinitely
  • Minimal—less than 5% of chelated complex activity
  • HPLC purity sufficient; no metal analysis needed
  • Useful as negative control in comparative studies; not a therapeutic candidate